The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Jun. 20, 2014
Applicant:

The General Hospital Corporation, Boston, MA (US);

Inventors:

Vineet Gupta, Glenview, IL (US);

M. Amin Arnaout, Chestnut Hill, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C07C 233/81 (2006.01); C07C 251/20 (2006.01); C07C 311/39 (2006.01); C07D 213/85 (2006.01); C07D 239/48 (2006.01); C07D 249/10 (2006.01); C07D 263/46 (2006.01); C07D 265/34 (2006.01); C07D 277/14 (2006.01); C07D 277/36 (2006.01); C07D 277/42 (2006.01); C07D 277/54 (2006.01); C07D 277/72 (2006.01); C07D 311/16 (2006.01); C07D 333/22 (2006.01); C07D 333/68 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 471/06 (2006.01); C07D 498/04 (2006.01); C07D 513/18 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5032 (2013.01); C07C 233/81 (2013.01); C07C 251/20 (2013.01); C07C 311/39 (2013.01); C07D 213/85 (2013.01); C07D 239/48 (2013.01); C07D 249/10 (2013.01); C07D 263/46 (2013.01); C07D 265/34 (2013.01); C07D 277/14 (2013.01); C07D 277/36 (2013.01); C07D 277/42 (2013.01); C07D 277/54 (2013.01); C07D 277/72 (2013.01); C07D 311/16 (2013.01); C07D 333/22 (2013.01); C07D 333/68 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 471/06 (2013.01); C07D 498/04 (2013.01); C07D 513/18 (2013.01); C07C 2601/14 (2017.05);
Abstract

The application describes an assay for the identification of small molecule modulators of integrin CD11b/CD18 and small molecules capable of modulating activity of this receptor. Such compounds may be used in certain embodiments for treating a disease or condition selected from inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, bullous pemphigoid, neonatal obstructive nephropathy, and cardiovascular disease, or in other embodiments for the treatment of a disease or condition selected from immune deficiency, acquired immune deficiency syndrome (AIDS), myeloperoxidase deficiency, Wiskott-Aldrich syndrome, chronic granulomatous disease, hyper-IgM syndromes, leukocyte adhesion deficiency, Chediak-Higashi syndrome, and severe combined immunodeficiency.


Find Patent Forward Citations

Loading…